| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | KRG | United States | $25.34 | $844,365,000.00 | Buy | 10 | 2004 |
#2 | TOST | United States | $29.74 | $6,153,000,000.00 | Buy | 22 | 2021 |
#3 | QNST | United States | $17.53 | $282,140,000.00 | Buy | 4 | 2009 |
#4 | AA | United States | $44.31 | $12,831,000,000.00 | Buy | 10 | 2016 |
#5 | AR | United States | $34.83 | $5,275,823,000.00 | Buy | 16 | 2013 |
#6 | RSI | United States | $23.33 | $1,134,428,000.00 | Strong Buy | 10 | 2020 |
#7 | IVT | United States | $30.79 | $299,169,000.00 | Buy | 7 | 2005 |
#8 | AMCR | Switzerland | $42.11 | $13,640,000,000.00 | Strong Buy | 8 | 2020 |
#9 | EQT | United States | $50.04 | $8,644,211,000.00 | Buy | 21 | 1994 |
#10 | KEY | United States | $20.91 | $7,513,000,000.00 | Buy | 15 | 2005 |
#11 | SON | United States | $48.83 | $7,518,753,000.00 | Buy | 9 | 2014 |
#12 | SMG | United States | $52.17 | $3,016,500,000.00 | Buy | 6 | 2012 |
#13 | FLYW | United States | $17.33 | $623,025,000.00 | Buy | 14 | 2021 |
#14 | TREE | United States | $25.58 | $1,117,324,000.00 | Strong Buy | 4 | 2008 |
#15 | GMED | United States | $74.06 | $2,938,931,000.00 | Buy | 14 | 2012 |
#16 | CSTM | France | $25.49 | $8,449,000,000.00 | Strong Buy | 4 | 2012 |
#17 | FAF | United States | $69.30 | $7,452,200,000.00 | Strong Buy | 4 | 2009 |
#18 | SHAK | United States | $54.83 | $1,445,306,000.00 | Buy | 26 | 2014 |
#19 | PRMB | United States | $20.54 | $6,664,000,000.00 | Buy | 9 | 2025 |
#20 | DEC | United States | $13.76 | $1,829,142,000.00 | Strong Buy | 8 | 2022 |
#21 | ASB | United States | $29.61 | $1,102,756,000.00 | Buy | 12 | 2014 |
#22 | PTCT | United States | $65.36 | $264,734,000.00 | Buy | 17 | 2006 |
#23 | RELY | United States | $21.87 | $1,635,147,000.00 | Buy | 7 | 2021 |
#24 | PACS | United States | $42.11 | $5,288,932,000.00 | Strong Buy | 4 | 2024 |
#25 | BJRI | United States | $59.60 | $0.00 | Buy | 8 | 1996 |
#26 | VTR | United States | $86.79 | $5,833,980,000.00 | Buy | 13 | 2005 |
#27 | FRPT | United States | $61.43 | $1,102,015,000.00 | Buy | 17 | 2014 |
#28 | LEVI | United States | $19.79 | $6,282,000,000.00 | Strong Buy | 12 | 2019 |
#29 | BMY | United States | $62.77 | $48,194,000,000.00 | Buy | 15 | 2006 |
#30 | BHRB | United States | $69.97 | $0.00 | Buy | 5 | 2023 |
#31 | ZVRA | United States | $11.60 | $106,470,000.00 | Strong Buy | 5 | 2015 |
#32 | BXMT | United States | $13.33 | $0.00 | Buy | 5 | 1998 |
#33 | NTST | United States | $18.18 | $195,006,000.00 | Strong Buy | 14 | 2020 |
#34 | APEI | United States | $43.84 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#35 | DRVN | United States | $12.28 | $1,862,438,000.00 | Buy | 8 | 2020 |
#36 | DRH | United States | $12.24 | $1,120,491,000.00 | Buy | 10 | 2004 |
#37 | SIRI | United States | $27.14 | $5,425,129,000.00 | Buy | 8 | 1996 |
#38 | CPT | United States | $99.51 | $12,967,000.00 | Buy | 17 | 1995 |
#39 | SPIR | United States | $11.45 | $110,451,000.00 | Strong Buy | 5 | 2020 |
#40 | UPST | United States | $24.99 | $1,043,857,000.00 | Buy | 16 | 2020 |
#41 | LTH | United States | $40.70 | $2,995,255,000.00 | Strong Buy | 7 | 2021 |
#42 | SWX | United States | $85.51 | $5,433,972,000.00 | Strong Buy | 5 | 2017 |
#43 | PFS | United States | $23.03 | $73,109,000.00 | Strong Buy | 4 | 2002 |
#44 | WGO | United States | $26.46 | $1,985,674,000.00 | Buy | 10 | 1994 |
#45 | WRBY | United States | $22.65 | $871,905,000.00 | Buy | 11 | 2021 |
#46 | SKYH | United States | $10.10 | $27,540,000.00 | Strong Buy | 4 | 2020 |
#47 | EPR | United States | $56.71 | $718,357,000.00 | Buy | 9 | 1997 |
#48 | NVST | United States | $23.35 | $2,566,500,000.00 | Buy | 13 | 2019 |
#49 | PUMP | United States | $10.55 | $1,269,158,000.00 | Buy | 7 | 2017 |
#50 | LINC | United States | $25.41 | $261,853,000.00 | Strong Buy | 4 | 2005 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (September 19, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.